Victory Capital Management Inc. lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 457,024 shares of the medical equipment provider’s stock after buying an additional 10,159 shares during the period. Victory Capital Management Inc. owned about 0.13% of Intuitive Surgical worth $224,522,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Hazlett Burt & Watson Inc. grew its position in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its stake in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC lifted its position in Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC increased its holdings in Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares during the period. Finally, Falcon Wealth Planning increased its holdings in Intuitive Surgical by 0.4% in the 3rd quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock valued at $2,797,000 after buying an additional 23 shares during the period. 83.64% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have weighed in on the company. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Piper Sandler reiterated an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Barclays increased their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. BTIG Research set a $535.00 price target on Intuitive Surgical in a report on Friday, October 18th. Finally, Wells Fargo & Company lifted their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $513.74.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Robert Desantis sold 396 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,680,761.28. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 396 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,680,761.28. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 68,006 shares of company stock valued at $33,727,766. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Price Performance
Shares of Intuitive Surgical stock traded down $3.39 during trading on Tuesday, hitting $532.36. The stock had a trading volume of 214,648 shares, compared to its average volume of 1,453,892. The firm’s fifty day simple moving average is $494.78 and its 200-day simple moving average is $453.94. The stock has a market cap of $189.62 billion, a PE ratio of 86.13, a PEG ratio of 5.27 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $281.12 and a 12 month high of $542.59.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Roth IRA Calculator: Calculate Your Potential Returns
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.